[1]
“The PERSPECTIVES OF BIOTECHNOLOGICAL DEVELOPMENT IN KAZAKHSTAN IN TERMS OF MONOCLONAL AND OTHER RECOMBINANT ANTIBODIES AND VACCINES AGAINST SARS-COV2”, EB, vol. 99, no. 2, pp. 173–188, Jun. 2024, doi: 10.26577/eb.2024.v99.i2.015.